vs
Side-by-side financial comparison of SMITH & WESSON BRANDS, INC. (SWBI) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($226.2M vs $124.7M, roughly 1.8× SMITH & WESSON BRANDS, INC.). SMITH & WESSON BRANDS, INC. runs the higher net margin — 1.5% vs 0.1%, a 1.5% gap on every dollar of revenue. On growth, SMITH & WESSON BRANDS, INC. posted the faster year-over-year revenue change (-3.9% vs -10.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (3.1% CAGR vs -4.8%).
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
SWBI vs USNA — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $124.7M | $226.2M |
| Net Profit | $1.9M | $180.0K |
| Gross Margin | 24.3% | 78.2% |
| Operating Margin | 3.3% | 1.7% |
| Net Margin | 1.5% | 0.1% |
| Revenue YoY | -3.9% | -10.0% |
| Net Profit YoY | -53.6% | -74.0% |
| EPS (diluted) | $0.04 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $124.7M | $226.2M | ||
| Q3 25 | $85.1M | $213.7M | ||
| Q2 25 | $140.8M | $235.8M | ||
| Q1 25 | $115.9M | $249.5M | ||
| Q4 24 | $129.7M | $213.6M | ||
| Q3 24 | $88.3M | $200.2M | ||
| Q2 24 | $159.1M | $212.9M | ||
| Q1 24 | $137.5M | — |
| Q4 25 | $1.9M | $180.0K | ||
| Q3 25 | $-3.4M | $-6.5M | ||
| Q2 25 | $8.6M | $9.7M | ||
| Q1 25 | $2.1M | $9.4M | ||
| Q4 24 | $4.5M | $4.5M | ||
| Q3 24 | $-1.9M | $10.6M | ||
| Q2 24 | $27.9M | $10.4M | ||
| Q1 24 | $7.9M | — |
| Q4 25 | 24.3% | 78.2% | ||
| Q3 25 | 25.9% | 77.2% | ||
| Q2 25 | 28.8% | 78.7% | ||
| Q1 25 | 24.1% | 79.0% | ||
| Q4 24 | 26.6% | 82.0% | ||
| Q3 24 | 27.4% | 80.4% | ||
| Q2 24 | 35.5% | 81.1% | ||
| Q1 24 | 28.7% | — |
| Q4 25 | 3.3% | 1.7% | ||
| Q3 25 | -3.5% | 0.6% | ||
| Q2 25 | 9.3% | 7.1% | ||
| Q1 25 | 4.1% | 6.3% | ||
| Q4 24 | 5.8% | 3.8% | ||
| Q3 24 | -1.7% | 7.8% | ||
| Q2 24 | 17.4% | 8.4% | ||
| Q1 24 | 8.2% | — |
| Q4 25 | 1.5% | 0.1% | ||
| Q3 25 | -4.0% | -3.1% | ||
| Q2 25 | 6.1% | 4.1% | ||
| Q1 25 | 1.8% | 3.8% | ||
| Q4 24 | 3.5% | 2.1% | ||
| Q3 24 | -2.1% | 5.3% | ||
| Q2 24 | 17.5% | 4.9% | ||
| Q1 24 | 5.7% | — |
| Q4 25 | $0.04 | $-0.10 | ||
| Q3 25 | $-0.08 | $-0.36 | ||
| Q2 25 | $0.19 | $0.52 | ||
| Q1 25 | $0.05 | $0.49 | ||
| Q4 24 | $0.10 | $0.23 | ||
| Q3 24 | $-0.04 | $0.56 | ||
| Q2 24 | $0.60 | $0.54 | ||
| Q1 24 | $0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.4M | $158.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $363.2M | — |
| Total Assets | $548.6M | $742.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.4M | $158.4M | ||
| Q3 25 | $18.0M | $145.3M | ||
| Q2 25 | $25.2M | $151.3M | ||
| Q1 25 | $26.7M | $179.6M | ||
| Q4 24 | $39.1M | $181.8M | ||
| Q3 24 | $35.5M | $364.9M | ||
| Q2 24 | $60.8M | $332.4M | ||
| Q1 24 | $47.4M | — |
| Q4 25 | $363.2M | — | ||
| Q3 25 | $364.4M | $528.1M | ||
| Q2 25 | $372.5M | $531.1M | ||
| Q1 25 | $366.9M | $529.8M | ||
| Q4 24 | $371.5M | $532.1M | ||
| Q3 24 | $380.0M | $533.1M | ||
| Q2 24 | $399.9M | $512.2M | ||
| Q1 24 | $376.4M | — |
| Q4 25 | $548.6M | $742.9M | ||
| Q3 25 | $554.6M | $726.6M | ||
| Q2 25 | $559.6M | $734.5M | ||
| Q1 25 | $578.9M | $746.6M | ||
| Q4 24 | $587.4M | $748.2M | ||
| Q3 24 | $571.3M | $671.3M | ||
| Q2 24 | $577.4M | $631.4M | ||
| Q1 24 | $570.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.3M | — |
| Free Cash FlowOCF − Capex | $16.3M | — |
| FCF MarginFCF / Revenue | 13.1% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 14.22× | — |
| TTM Free Cash FlowTrailing 4 quarters | $21.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | — | ||
| Q3 25 | $-8.1M | $-2.0M | ||
| Q2 25 | $40.8M | $12.2M | ||
| Q1 25 | $-9.8M | $15.5M | ||
| Q4 24 | $-7.4M | $5.8M | ||
| Q3 24 | $-30.8M | $29.5M | ||
| Q2 24 | $43.7M | $8.0M | ||
| Q1 24 | $25.2M | — |
| Q4 25 | $16.3M | — | ||
| Q3 25 | $-12.4M | $-5.2M | ||
| Q2 25 | $33.5M | $7.2M | ||
| Q1 25 | $-16.1M | $12.7M | ||
| Q4 24 | $-10.7M | $4.0M | ||
| Q3 24 | $-35.5M | $27.1M | ||
| Q2 24 | $38.2M | $5.3M | ||
| Q1 24 | $7.0M | — |
| Q4 25 | 13.1% | — | ||
| Q3 25 | -14.6% | -2.4% | ||
| Q2 25 | 23.8% | 3.0% | ||
| Q1 25 | -13.9% | 5.1% | ||
| Q4 24 | -8.3% | 1.9% | ||
| Q3 24 | -40.2% | 13.6% | ||
| Q2 24 | 24.0% | 2.5% | ||
| Q1 24 | 5.1% | — |
| Q4 25 | 8.8% | — | ||
| Q3 25 | 5.0% | 1.5% | ||
| Q2 25 | 5.2% | 2.1% | ||
| Q1 25 | 5.4% | 1.1% | ||
| Q4 24 | 2.5% | 0.8% | ||
| Q3 24 | 5.3% | 1.2% | ||
| Q2 24 | 3.5% | 1.3% | ||
| Q1 24 | 13.2% | — |
| Q4 25 | 14.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.73× | 1.27× | ||
| Q1 25 | -4.68× | 1.65× | ||
| Q4 24 | -1.63× | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | 1.57× | 0.77× | ||
| Q1 24 | 3.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
